Clinical Trial: Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07190651) titled 'Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy' on Sept. 17.

Brief Summary: This study aims to develop and prospectively validate a questionnaire to select patients with breast cancer who need to access to hospital for clinical visit during treatment with CDK4/6i, to improve patients' quality of life and reduce burden of hospital accesses.

Study Start Date: Oct. 01

Study Type: OBSERVATIONAL

Condition: Breast Cancer CDK4/6 Inhibitor

Intervention: OTHER: Home questionnaire

Administration of a questionnaire at each 28-days cycle, to s...